190 related articles for article (PubMed ID: 26604850)
1. Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients.
Jafri SH; Previgliano C; Khandelwal K; Shi R
Clin Med Insights Oncol; 2015; 9():87-93. PubMed ID: 26604850
[TBL] [Abstract][Full Text] [Related]
2. Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma.
Aslan V; Kılıç ACK; Sütcüoğlu O; Eraslan E; Bayrak A; Öksüzoğlu B; Tahtacı G; Özdemir N; Üner A; Günel N; Özet A; Yazıcı O
Urol Oncol; 2022 Nov; 40(11):494.e1-494.e10. PubMed ID: 36137881
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of the Cachexia Index in Patients with Non-Small-Cell Lung Cancer and Brain Metastases after Stereotactic Radiotherapy.
Xu H; Zhang B; Zhang Y; Yang C; Bo C; Guo Y; Cheng Y; He L
Clin Med Insights Oncol; 2024; 18():11795549231222362. PubMed ID: 38440045
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy.
Goh MJ; Kang W; Jeong WK; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Sci Rep; 2022 May; 12(1):7647. PubMed ID: 35538112
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of the cachexia index in patients with small cell lung cancer.
Go SI; Park MJ; Lee GW
BMC Cancer; 2021 May; 21(1):563. PubMed ID: 34001060
[TBL] [Abstract][Full Text] [Related]
6. Hand grip strength-based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer.
Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Lin S; Song M; Zhang X; Liu X; Li X; Zhang K; Yang M; Tang M; Song CH; Gan J; Shi HP
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):382-390. PubMed ID: 36447437
[TBL] [Abstract][Full Text] [Related]
7. Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B-cell lymphoma.
Go SI; Park MJ; Park S; Kang MH; Kim HG; Kang JH; Kim JH; Lee GW
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2211-2219. PubMed ID: 34676685
[TBL] [Abstract][Full Text] [Related]
8. Cachexia Index as a Prognostic Indicator in Patients with Gastric Cancer: A Retrospective Study.
Gong C; Wan Q; Zhao R; Zuo X; Chen Y; Li T
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139560
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the cachexia index based on hand-grip strength (H-CXI) with the original CXI for the prediction of cancer cachexia and prognosis in patients who underwent radical colectomy for colorectal cancer.
Yan XL; Wu LM; Tang XB; Li ZZ; Zhang Z; Jiang HJ; Chen ZT; Chen DH; Li JY; Shen X; Huang DD
Front Nutr; 2024; 11():1290299. PubMed ID: 38445206
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin's lymphoma: A single-center prospective study.
Okubo S; Shinmura K; Kadota S; Nakayasu M; Kurosawa S; Nakayama H; Sakurai A; Ito C; Aisa Y; Nakazato T
Ann Hematol; 2024 Mar; 103(3):823-831. PubMed ID: 38010408
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cachexia index in patients with colorectal cancer: A retrospective study.
Wan Q; Yuan Q; Zhao R; Shen X; Chen Y; Li T; Song Y
Front Oncol; 2022; 12():984459. PubMed ID: 36212479
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the cachexia index as a prognostic indicator for patients with gastric cancer.
Nakashima K; Haruki K; Kamada T; Takahashi J; Nakaseko Y; Ohdaira H; Furukawa K; Suzuki Y; Ikegami T
Ann Gastroenterol Surg; 2023 Sep; 7(5):733-740. PubMed ID: 37663966
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of cachexia index in patients with hepatocellular carcinoma after hepatic resection.
Akaoka M; Haruki K; Taniai T; Yanagaki M; Igarashi Y; Furukawa K; Onda S; Tsunematsu M; Shirai Y; Okui N; Gocho T; Ikegami T
Surg Oncol; 2022 Dec; 45():101881. PubMed ID: 36371905
[TBL] [Abstract][Full Text] [Related]
14. Preoperative cachexia index can predict the prognosis of extrahepatic biliary tract cancer after resection.
Hamura R; Haruki K; Shirai Y; Tanji Y; Taniai T; Okui N; Furukawa K; Shiozaki H; Onda S; Ikegami T
Surg Oncol; 2022 Sep; 44():101825. PubMed ID: 35947886
[TBL] [Abstract][Full Text] [Related]
15. The Cancer Cachexia Index Can Be Used to Prognostically Predict Patients with Gastric Cancer Undergoing Gastrectomy.
Sakurai K; Kubo N; Hasegawa T; Nishimura J; Iseki Y; Nishii T; Inoue T; Yashiro M; Nishiguchi Y; Maeda K
Ann Nutr Metab; 2023; 79(6):511-521. PubMed ID: 37751717
[TBL] [Abstract][Full Text] [Related]
16. Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
Brown LR; Thomson GG; Gardner E; Chien S; McGovern J; Dolan RD; McSorley ST; Forshaw MJ; McMillan DC; Wigmore SJ; Crumley AB; Skipworth RJE
Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38593042
[TBL] [Abstract][Full Text] [Related]
17. Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous cell carcinoma.
Brkic FF; Kadletz L; Jank B; Mayer C; Heiduschka G; Brunner M
J Craniomaxillofac Surg; 2020 Jan; 48(1):33-37. PubMed ID: 31810849
[TBL] [Abstract][Full Text] [Related]
18. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of the SUVmax Measured From FDG PET and Neutrophil-to-lymphocyte Ratio Improves Prediction of Clinical Outcomes in Patients With Locally Advanced Non-small-cell Lung Cancer.
Guo D; Jin F; Jing W; Li M; Chen D; Zou B; Jiang G; Fu L; Zhu H; Kong L; Wu J; Yu J; Yue J
Clin Lung Cancer; 2019 Nov; 20(6):412-419. PubMed ID: 31300364
[TBL] [Abstract][Full Text] [Related]
20. Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma.
Shimagaki T; Sugimachi K; Mano Y; Onishi E; Iguchi T; Nakashima Y; Sugiyama M; Yamamoto M; Morita M; Toh Y
Ann Gastroenterol Surg; 2023 Nov; 7(6):977-986. PubMed ID: 37927935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
